1. Home
  2. BWAY vs LNKB Comparison

BWAY vs LNKB Comparison

Compare BWAY & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • LNKB
  • Stock Information
  • Founded
  • BWAY 2003
  • LNKB 2018
  • Country
  • BWAY Israel
  • LNKB United States
  • Employees
  • BWAY N/A
  • LNKB N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • LNKB
  • Sector
  • BWAY Health Care
  • LNKB
  • Exchange
  • BWAY Nasdaq
  • LNKB Nasdaq
  • Market Cap
  • BWAY 280.7M
  • LNKB 266.2M
  • IPO Year
  • BWAY 2019
  • LNKB N/A
  • Fundamental
  • Price
  • BWAY $15.20
  • LNKB $7.40
  • Analyst Decision
  • BWAY Strong Buy
  • LNKB Strong Buy
  • Analyst Count
  • BWAY 2
  • LNKB 1
  • Target Price
  • BWAY $18.00
  • LNKB $9.00
  • AVG Volume (30 Days)
  • BWAY 70.6K
  • LNKB 36.8K
  • Earning Date
  • BWAY 08-13-2025
  • LNKB 07-28-2025
  • Dividend Yield
  • BWAY N/A
  • LNKB 4.19%
  • EPS Growth
  • BWAY 515.14
  • LNKB N/A
  • EPS
  • BWAY 0.11
  • LNKB 1.01
  • Revenue
  • BWAY $46,084,000.00
  • LNKB $121,982,000.00
  • Revenue This Year
  • BWAY $341.83
  • LNKB $21.03
  • Revenue Next Year
  • BWAY $23.42
  • LNKB N/A
  • P/E Ratio
  • BWAY $52.60
  • LNKB $7.33
  • Revenue Growth
  • BWAY 26.50
  • LNKB 79.01
  • 52 Week Low
  • BWAY $7.06
  • LNKB $6.00
  • 52 Week High
  • BWAY $15.61
  • LNKB $7.98
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 78.88
  • LNKB 58.41
  • Support Level
  • BWAY $14.33
  • LNKB $7.07
  • Resistance Level
  • BWAY $15.00
  • LNKB $7.25
  • Average True Range (ATR)
  • BWAY 0.56
  • LNKB 0.20
  • MACD
  • BWAY 0.33
  • LNKB 0.04
  • Stochastic Oscillator
  • BWAY 90.26
  • LNKB 84.88

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About LNKB LINKBANCORP Inc.

Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.

Share on Social Networks: